Navigation Links
50 Years Old and Still Bounding Over the Counter: Kline's Healthcare Practice Continues to Deliver Unmatched OTC Market Intelligence
Date:9/24/2013

PARSIPPANY, N.J., Sept. 24, 2013 /PRNewswire/ -- With over half a century of market insights on the U.S. consumer healthcare market, Kline & Company expects that new paradigm shifts in regulations, retail, and technology will create new opportunities for medications to move along the Rx-to-OTC continuum and more growth prospects for the U.S. OTC market. Additionally, with the OTC medication market in the United States nearing $23 billion in 2012 alone and with the FDA - through its recent NSURE (Nonprescription Safe Use Regulatory Expansion) initiative - showing encouraging indications that it is becoming more receptive to allowing more Rx-to-OTC switches, the U.S. OTC market is fast returning to pre-recession health.   

Celebrating its 50th anniversary, Kline's distinguished Nonprescription Drugs USA report continues to provide the most comprehensive market intelligence expanding its longstanding OTC drugs industry know-how to include indispensable research on related topics including Natural OTCs, OTC Retailing, OTC Innovations, Impact of Recessions on the U.S. OTC Market, OTC Drugs: U.S. Competitor Cost Structures, OTC Consumer/Shopper Insights and a series of reports on Rx-to-OTC Switch.

In recent years, the U.S. OTC market has been hindered by significant product recalls by major players, with the resultant vacuum - abetted by recession-affected ever cost-conscious consumers - largely claimed by private-label alternatives. Laura Mahecha, industry manager at Kline's Healthcare Practice, adds, "The impact and profound magnitude of ongoing economic uncertainty is borne out by more than half of respondents in a recent Kline survey disclosing that they'd changed how they purchased OTC drugs. Specifically, nearly a quarter of those surveyed choose private label OTC drugs whenever possible because of their perceived cost advantage."

Despite the stronghold private-label products have on the market and the highly competitive nature of this market, there is still room for OTC brands to grow and prosper in the coming years with increased focus from major companies on innovations, new product launches and line extensions, and strategic marketing plans.

Currently, Rx-to-OTC switches continue to be a major force driving the OTC market as they increasingly involve large widely used products and drive demand by bringing ex-Rx users to the OTC market. Major Rx-to-OTC switches introduced since 1976 account for nearly $4,555 million in sales in 2012 and represent 32.8% of overall OTC sales (excluding home diagnostics, vitamins and minerals, and herbal products).  The increased numbers of switch approvals by the FDA are expected to lead to future gains for the U.S. OTC market and could even create brand new, never-before-available-without-a-prescription categories.

The U.S. OTC market has evolved markedly, beginning with the FDA establishing an OTC review/Monograph system in the 1970s and the landmark Rx-to-OTC switch of hydrocortisone and its subsequent inclusion in OTC first-aid and anti-itch medications. The 1980s saw a recession fuelled spike in private-label OTC sales and the approval of ibuprofen as an OTC drug, in addition to the approval of many allergy, cough, and cold ingredients bringing brands like Nyquil, Benadryl, Triaminic, and Actifed to market.

View our 50 year overview graphic on EVOLUTION OF THE U.S. OTC MARKET 1963-2013.
Download the file HERE or copy paste http://bit.ly/50yearsNPD.

There are challenges for OTC marketers including but not limited to private-label competition, retailer SKU rationalization, cost-conscious consumers, consolidated number of competitors, and increased scrutiny of manufacturing and quality assurance procedures.  However, opportunities exist to see increased levels of growth over the next few years for the companies that have solid brands, good claims, strategic marketing, a steady stream of innovations and line extensions, and efficient and compliant processes.

About Kline
Kline is a worldwide consulting and research firm dedicated to providing the kind of insight and knowledge that helps companies find a clear path to success. The firm has served the management consulting and market research needs of organizations in the chemicals, materials, energy, life sciences, and consumer products industries for over 50 years. For more information, visit www.KlineGroup.com.

For more information, contact:

Vera Sandarova
Marketing Communications
+420-222-33-00-13
Vera.Sandarova@klinegroup.com


'/>"/>
SOURCE Kline & Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Richard Wolf Medical Instruments Corporation: 40 Years of Innovation
2. CalHIPSO Enrolls Over 7,700 Providers in EHR Implementation Program, Hits Other Key Milestones After First Two Years
3. Ceregene Parkinsons Disease Study Demonstrates Long-term Neurturin Expression and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin)
4. NAMS Journal Menopause Reflects on the WHI 10 Years Later
5. Particle Measuring Systems® Celebrates 40 Years of Leadership
6. Leading Pension Annuity Provider Legal & General, Celebrates 175 Years
7. Multiple Sclerosis Association of Americas MRI Institute Marks 10 Years of Helping Individuals with Multiple Sclerosis Obtain MRIs
8. Abbott, The Abbott Fund And Direct Relief International Reach Key HIV Testing Milestones: 20 Million Tests Provided Over 10 Years, And More Than 150,000 HIV Cases Prevented In Children
9. Ranbaxy Commends New IMS Study Which Credits Generic Prescription Drugs With $1 Trillion Savings In U.S. Health Care Costs Over Past 10 Years
10. Protection Against Whooping Cough Waned During the Five Years After Fifth Dose of DTaP
11. Bethesda Health Clinic Utilizes Donated MedInformatix EHR for Nine Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... , Dec. 9, 2016   Hudes Laser ... December featuring the multi-wavelength Astanza Trinity laser and ... specializes in laser tattoo removal, IPL hair removal, ... ultrasound therapy. Hudes Laser Aesthetica is setting high ... and promises to deliver effective, long-lasting ...
(Date:12/9/2016)... OSAKA, Japan , Dec. 9, 2016 ... ; President & Representative Director, CEO: Dr. ... with amyotrophic lateral sclerosis (ALS) given edaravone intravenously in ... functional loss as measured by the ALS Functional Rating ... th International Symposium on ALS/MND in ...
(Date:12/9/2016)... 9, 2016  Axovant Sciences Ltd. (NYSE: ... focused on the treatment of dementia, today announced ... Phase 2b trial evaluating treatment with intepirdine (RVT-101), ... donepezil plus placebo in people with mild-to-moderate Alzheimer,s ... intepirdine to treatment was associated with reduced progression ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) aired ... of 2016. The program was made possible by a Pennsylvania Department of Health ... and Human Services Administration. The broadcast, Use Your Head: Properly Managing Sport ...
(Date:12/8/2016)... ... 2016 , ... The Florida Hospital Tampa Wound Healing Institute ... (UHMS), the leading authority in hyperbaric medicine. This accreditation identifies the Institute as ... facilities have earned this distinction. This is the second time the Florida Hospital ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... and JENNERSVILLE, Pa. (PRWEB) , ... December 08, ... ... that Penn Medicine Southern Chester County, a Property owned by an affiliate of ... million, 72,000 square foot Penn Medicine Southern Chester County ambulatory care center (ACC) ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused ... in efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, ... is honored to team up with Upstage Lung Cancer in order to make major ...
Breaking Medicine News(10 mins):